ICU — Investor Centre Income Statement
0.000.00%
Last trade - 00:00- AU$0.61m
- AU$3.16m
- AU$0.48m
Annual income statement for Investor Centre, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.31 | 2.32 | 2.94 | 1.29 | 0.478 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 6.9 | 3.34 | 4.27 | 2.62 | 2.22 |
| Operating Profit | -5.59 | -1.02 | -1.33 | -1.33 | -1.74 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -5.72 | -1.2 | -3.11 | -1.41 | -1.94 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -5.72 | -1.2 | -3.11 | -1.41 | -1.94 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -5.72 | -1.2 | -3.11 | -1.41 | -1.94 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -5.72 | -1.2 | -3.11 | -1.41 | -1.94 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.02 | -0.015 | -0.028 | -0.007 | -0.006 |